Work

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.4023.4023

Authors: Diana Cirstea, Teru Hideshima, Loredana Santo, Homare Eda, Tyler A. Scullen, Neeharika Nemani, Anuj Mahindra, Andrew Yee, Yiguo Hu, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Rikio Suzuki, Francesca Cottini, Sylvie M Guichard, Kenneth C. Anderson, Noopur Raje

Institutions: Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, AstraZeneca (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2580458132

FWCI:

Cites:

Cited by:

Related to: 10